> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# REMS Web Site Updates Listed
- URL: https://www.fdaweb.com/rems-web-site-updates-listed/
- Published: 2020-07-07T12:00:00.000Z
- Updated: 2026-09-14T16:20:08.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5147140

FDA has published a list of REMS updates for five drug products. The list shows changes for Akcea’s Tegsedi (inotersen), Celgene’s Pomalyst (pomalidomide), Takeda’s Natpara (parathyroid hormone), Indivior’s Sublocade (buprenorphine extended-release), and Zogenix’ Fintepla (fenfluramine).